Abstract
We have developed an efficient system for obtaining myeloma mutants defective intrans-acting factors required for immunoglobulin (Ig) gene expression. The system consists of a myeloma cell line designed for this purpose and an efficient method for selecting mutants from it. The cell line is X63.653 transfected with the μ gene, whose tailpiece sequence was replaced with the transmembrane sequence of human EGF receptor to hold μ on the cell surface and whose CH1 sequence was removed to prevent μ from being retained in the endoplasmic reticulum. It efficiently and stably expressed μ chains of IgM on the cell surface (μ +m ) without light chains. To obtain mutants lacking μm (μ −m ) from the μ +m cell line by selectively killing μ +m cells, a method with ricin A-conjugated anti-μ antibody was more reliable than complement lysis mediated by anti-μ antibody. Applying the system, we obtained a variety of μ −m mutants.
Similar content being viewed by others
Literature cited
Maniatis, T., Goodbourn, S., and Fisher, J.A. (1987).Science 2361237–1245.
Baeuerle, P.A. (1991).Biochim. Biophys. Acta 107263–80.
Müller, M.M., Ruppert, S., Schaffner, W., and Matthias, P. (1988).Nature 336544–551.
Scheidereit, C., Cromlish, J.A., Gerster, T., Kawakami, K., Balmaceda, C.G., Currie, R.A., and Roeder, R.G. (1988).Nature 336551–557.
Weitzman, S., and Scharff, M.D. (1976).J. Mol. Biol. 102237–252.
Shulman, M.J., Heusser, C., Filkin, C., and Köhler, G. (1982).Mol. Cell. Biol. 21033–1043.
Trimble, W.S., Baker, M.D., Boulianne, G.L., Murialdo, H., Hozumi, N., and Shulman, M.J. (1986).Somat. Cell Mol. Genet. 12467–477.
Atchison, M.L., and Perry, R.P. (1987).Cell 48121–128.
Neuberger, M.S. (1983).EMBO J. 21373–1378.
Ueda, H., Kikuchi, M., Yagi, S., and Nishimura, H. (1992).Bio/Technol. 10430–433.
Kearney, J.F., Radbruch, A., Liesegang, B., and Rajewsky, K. (1979).J. Immunol. 1231548–1550.
Lambson, B.E., Bernstein, R., and Mendelow, B.V. (1990).Somat. Cell Mol. Genet. 1691–95.
Potter, H., Weir, L., and Leder, P. (1984).Proc. Natl. Acad. Sci. U.S.A. 817161–7165.
Seon, B.K. (1984).Cancer Res. 44259–264.
Cumber, A.J., Forrester, J.A., Foxwell, B.M.J., Ross, W.C.J., and Thorpe, P.E. (1985).Methods Enzymol. 112207–225.
Behzadian, M.A., and Shimizu, N. (1985).Somat. Cell Mol. Genet. 11579–591.
Youle, R.J., and Neville, D.M., Jr. (1980).Proc. Natl. Acad. Sci. U.S.A. 775483–5486.
Haas, I.G., and Wabl, M. (1983).Nature 306387–389.
Bole, D.G., Hendershot, L.M., and Kearney, J.F. (1986).J. Cell Biol. 1021558–1566.
Hendershot, L., Bole, D., Köhler, G., and Kearney, J.F. (1987).J. Cell Biol. 104761–767.
Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K., and Reth, M. (1988).EMBO J. 73451–3456.
Hombach, J., Tsubata, T., Leclercq, L., Stappert, H., and Reth, M. (1990).Nature 343760–762.
Sitia, R., Neuberger, M.S., and Milstein, C. (1987).EMBO J. 63969–3977.
Sitia, R., Neuberger, M., Alberini, C., Bet, P., Fra, A., Valetti, C., Williams, G., and Milstein, C. (1990).Cell 60781–790.
Shaw, A.C., Mitchell, R.N., Weaver, Y.K., Campos-Torres, J., Abbas, A.K., and Leder, P. (1990).Cell 63381–392.
Köhler, G., and Shulman, M.J. (1980).Eur. J. Immunol. 10467–476.
Andrews-Wagner, R., and Silbey, C. (1983).Somat. Cell Mol. Genet. 943–54.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shindo, T., Ueda, H., Makishima, F. et al. Efficient selection of μ −m mutants from μm-expressing myeloma cells by treatment with ricin A-conjugated anti-μ antibody. Somat Cell Mol Genet 18, 553–558 (1992). https://doi.org/10.1007/BF01232651
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01232651